Skip to content

Cerus CERS Total Cost of Revenue

Total Cost of Revenue at other companies

Haemonetics logo
HaemoneticsHAE
$148.14M+7.7%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$282.7M+1.2%
QuidelOrtho Corporation logo
QuidelOrtho CorporationQDEL
$356M+1.9%
ADMA Biologics logo
ADMA BiologicsADMA
$33.74M-37.2%
Paysign logo
PaysignPAYS
$9.82M+42.2%

Other financials

Income statement

See full
Revenue$53.7M+24.1%
Operating income-$354.0K+94.0%
Net income-$1.6M+78.7%
EPS (diluted)-$0.01+75.0%

Balance sheet

See full
Cash & equivalents$27.9M+43.0%
Total debt$45.0M-43.3%
Total equity$67.6M+21.7%
Total assets$222.9M+7.8%

Cash flow

See full
Operating cash flow-$3.0M-261%
CapEx$233.0K+108%
Free cash flow-$3.3M-243%

Valuation

See full
Market cap$573.06M+124%
Enterprise value$590.17M+86.7%
P/S2.9×-1.0×

Profitability

See full
Gross margin64%
Operating margin-6.2%-2.1pp
Net margin-9.8%-2.8pp
FCF margin3.5%+1.9pp

Returns & leverage

See full
Return on equity-15.5%-5.6pp
Debt / equity0.7×-0.8×
Current ratio1.6×-0.7×

Where this comes from

Reported directly by Cerus in its filing.

Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.

The official record: Cerus’s 10-Q, filed November 2, 2021, on SEC EDGAR. View the filing →

Ask your AI about Cerus's total cost of revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cerus's total cost of revenue?
Cerus (CERS) reported total cost of revenue of $17.58M in Q3 2021.
What does total cost of revenue mean?
The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.